169 related articles for article (PubMed ID: 37197689)
1. Increased fluorescence observation intensity during the photodynamic diagnosis of deeply located tumors by fluorescence photoswitching of protoporphyrin IX.
Ogbonna SJ; York WY; Nishimura T; Hazama H; Fukuhara H; Inoue K; Awazu K
J Biomed Opt; 2023 May; 28(5):055001. PubMed ID: 37197689
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence detection of deep intramucosal cancer excited by green light for photodynamic diagnosis using protoporphyrin IX induced by 5-aminolevulinic acid: an ex vivo study.
Ihara D; Hazama H; Nishimura T; Morita Y; Awazu K
J Biomed Opt; 2020 Mar; 25(6):1-13. PubMed ID: 32129029
[TBL] [Abstract][Full Text] [Related]
3. Mass Spectrometric Analysis of the Photobleaching of Protoporphyrin IX Used in Photodynamic Diagnosis and Therapy of Cancer.
Ogbonna SJ; Hazama H; Awazu K
Photochem Photobiol; 2021 Sep; 97(5):1089-1096. PubMed ID: 33687739
[TBL] [Abstract][Full Text] [Related]
4. The photosensitizing effect of the photoproduct of protoporphyrin IX.
Ma L; Bagdonas S; Moan J
J Photochem Photobiol B; 2001 Jul; 60(2-3):108-13. PubMed ID: 11470566
[TBL] [Abstract][Full Text] [Related]
5. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
6. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
[No Abstract] [Full Text] [Related]
7. Identification of excimer delayed fluorescence by Protoporphyrin IX: A novel access to local chromophore concentration?
Croizat G; Gregor A; Joniova J; Gerelli E; Wagnières G
J Photochem Photobiol B; 2022 Apr; 229():112408. PubMed ID: 35294918
[TBL] [Abstract][Full Text] [Related]
8. Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study.
Bagdonas S; Ma LW; Iani V; Rotomskis R; Juzenas P; Moan J
Photochem Photobiol; 2000 Aug; 72(2):186-92. PubMed ID: 10946571
[TBL] [Abstract][Full Text] [Related]
9. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
10. Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
Chan KM; Vasilev K; Shirazi HS; McNicholas K; Li J; Gleadle J; MacGregor M
Photodiagnosis Photodyn Ther; 2019 Dec; 28():238-247. PubMed ID: 31394301
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.
Ritz R; Scheidle C; Noell S; Roser F; Schenk M; Dietz K; Strauss WS
PLoS One; 2012; 7(12):e51974. PubMed ID: 23251668
[TBL] [Abstract][Full Text] [Related]
12. Improvement of aminolevulinic acid (ALA)-mediated photodynamic diagnosis using n-propyl gallate.
Hirano T; Hagiya Y; Fukuhara H; Inoue K; Shuin T; Matsumoto K; Inoue K; Tanaka T; Okura I; Ogura S
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):28-32. PubMed ID: 23465369
[TBL] [Abstract][Full Text] [Related]
13. Opto-microfluidic assisted synthesis of photo-protoporphyrin (pPP) conjugated to hollow gold-albumin hybrid nanoshells to enhance the efficiency of photodynamic therapy of triple negative breast cancer cells.
Imanparast A; Shaegh SAM; Attaran N; Ameri AR; Sazgarnia A
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103632. PubMed ID: 37236519
[TBL] [Abstract][Full Text] [Related]
14. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
16. Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy.
Tyrrell J; Campbell S; Curnow A
Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):232-8. PubMed ID: 21112545
[TBL] [Abstract][Full Text] [Related]
17. Catechin reduces phototoxic effects induced by protoporphyrin IX-based photodynamic therapy in the chick embryo chorioallantoic membrane.
Joniová J; Wagnières G
J Biomed Opt; 2020 Feb; 25(6):1-9. PubMed ID: 32052612
[TBL] [Abstract][Full Text] [Related]
18. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Tyrrell JS; Morton C; Campbell SM; Curnow A
Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
[TBL] [Abstract][Full Text] [Related]
19. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.
Cottrell WJ; Paquette AD; Keymel KR; Foster TH; Oseroff AR
Clin Cancer Res; 2008 Jul; 14(14):4475-83. PubMed ID: 18628462
[TBL] [Abstract][Full Text] [Related]
20. Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis.
de Bruijn HS; Kruijt B; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photochem Photobiol Sci; 2007 Aug; 6(8):857-64. PubMed ID: 17668116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
